期刊文献+

非肝病性高血氨在重症患者中值得关注 被引量:3

Attention should be paid to non-hepatic hyperammonemia in severe patients
下载PDF
导出
摘要 血氨作为体内氨基酸的主要代谢产物,在物质代谢和生物转化过程中发挥重要作用。现阶段的研究多是针对肝脏疾病导致的高血氨及氨中毒学说,而非肝脏疾病导致血氨增加的原因以及高血氨对于其他脏器功能的影响一直被忽视。无基础肝病(急性肝衰竭或慢性肝病),由其他原因引起的血氨增高被称为非肝病性高血氨(non-hepatic hyperammonemia,NHH),目前NHH尚未引起临床广泛重视。本文将针对重症患者发生NHH的病理生理机制、临床意义以及血氨与疾病的关系进行探讨,希望对相关疾病的临床诊断、病情评估和治疗有所启发。 As the main metabolite of amino acid in vivo,blood ammonia plays an important role in the process of material metabolism and biotransformation.Current studies tend to focus on the theory of high blood ammonia and ammonia poisoning caused by liver diseases,but the reasons for the increase of blood ammonia caused by non-liver diseases and the effects of high blood ammonia on other organ functions have been neglected.At present,it is believed that the increase of blood ammonia caused by other causes in patients without hepatic disease(acute liver failure or chronic liver disease)is referred to as non-hepatic hyperammonemia(NHH).However,at present,NHH has not been paid much attention by the clinicians.In this paper,the pathophysiological mechanism,clinical significance and the relationship between blood ammonia find disease in severe patients with NHH are discussed in the hope of that it will be helpful to clinical diagnosis,assessment and treatment of related diseases.
作者 姚志鹏 王洪亮 Yao Zhi - peng;Wang Hong - liang(Intensive Care Unit,the Second Hospital Affliated Harbin Medical University,Harbin 150080,China)
出处 《中国急救医学》 CAS CSCD 北大核心 2019年第4期313-315,共3页 Chinese Journal of Critical Care Medicine
关键词 非肝病性高血氨(NHH) 氨基酸代谢 重症患者 血氨检测 Non-hepatic hyperammonemia(NHH) Metabolism of amino acid Severe patients Blood ammonia detection
  • 相关文献

参考文献1

二级参考文献20

  • 1Tilg H,Wilmer A,Vogel W,Herold M,N?lchen B,Judmaier G,Huber C.Serum levels of cytokines in chronic liver diseases[].Gastroenterology.1992
  • 2Pablo Bellot,Rubén Francés,Jose Such.Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications[J].Liver Int.2012(1)
  • 3Kavish R. Patidar,Jasmohan S. Bajaj.Antibiotics for the treatment of hepatic encephalopathy[J].Metabolic Brain Disease.2013(2)
  • 4Wasmuth Hermann E,Kunz Dagmar,Yagmur Eray,Timmer-Strangh?ner Annette,Vidacek Daniel,Siewert Elmar,Bach Jens,Geier Andreas,Purucker Edmund A,Gressner Axel M,Matern Siegfried,Lammert Frank.Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. Journal of Hepatology . 2005
  • 5Reiner Wiest,Melissa Lawson,Markus Geuking.Pathological bacterial translocation in liver cirrhosis[J]. Journal of Hepatology . 2014 (1)
  • 6Adrian Dominik,Jan Stange,Claudia Pfensig,Luise Borufka,Helga Weiss‐Reining,Martin Eggert.Reduction of Elevated Cytokine Levels in A cute/ A cute‐on‐Chronic Liver Failure Using Super‐Large Pore Albumin Dialysis Treatment: An In Vitro Study[J]. Ther Apher Dial . 2014 (4)
  • 7N. Kimer,A. Krag,S. M?ller,F. Bendtsen,L. L. Gluud.Systematic review with meta‐analysis: the effects of rifaximin in hepatic encephalopathy[J]. Aliment Pharmacol Ther . 2014 (2)
  • 8Anne Chastre,Mireille Bélanger,Bich N. Nguyen,Roger F. Butterworth.Lipopolysaccharide precipitates hepatic encephalopathy and increases blood–brain barrier permeability in mice with acute liver failure[J]. Liver Int . 2014 (3)
  • 9Lokesh Jain,Barjesh Chander Sharma,Siddharth Srivastava,Sunil Kumar Puri,Praveen Sharma,Shiv Sarin.Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy[J]. J Gastroenterol Hepatol . 2013 (7)
  • 10Lise Lotte Gluud,Gitte Dam,Mette Borre,I?igo Les,Juan Cordoba,Giulio Marchesini,Niels Kristian Aagaard,Hendrik Vilstrup.Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?[J]. Metabolic Brain Disease . 2013 (2)

共引文献17

同被引文献11

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部